About Blueberry Therapeutics
Blueberry Therapeutics is a company based in Alderley Edge (United Kingdom) founded in 2011 by Michael John Davies.. Blueberry Therapeutics has raised $23.77 million across 5 funding rounds from investors including Maven Capital Partners, China Medical System and Medical Incubator Japan. The company has 16 employees as of May 31, 2021. Blueberry Therapeutics offers products and services including Nanopolymer Drug Delivery System and Therapy for Onychomycosis. Blueberry Therapeutics operates in a competitive market with competitors including Sirnaomics, Acorda, Liquidia, Genedit and NanoSyrinx, among others.
- Headquarter Alderley Edge, United Kingdom
- Employees 16 as on 31 May, 2021
- Founders Michael John Davies
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Blueberry Therapeutics Limited
- Date of Incorporation 08 Nov, 2011
- Jurisdiction MACCLESFIELD, CHESHIRE, UNITED KINGDOM
-
Annual Revenue
$615.53 K (USD)0as on May 31, 2019
-
Net Profit
$-3.76 M (USD)-37as on May 31, 2022
-
EBITDA
$-4.68 M (USD)1as on May 31, 2022
-
Total Equity Funding
$23.77 M (USD)
in 5 rounds
-
Latest Funding Round
$1.06 M (USD), Debt – Conventional
Jun 08, 2021
-
Investors
Maven Capital Partners
& 5 more
-
Employee Count
16
as on May 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blueberry Therapeutics
Blueberry Therapeutics offers a comprehensive portfolio of products and services, including Nanopolymer Drug Delivery System and Therapy for Onychomycosis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced system for topical drug delivery to treat skin disorders effectively.
Nanomedicine-based treatment for fungal nail infections and related conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Blueberry Therapeutics
Blueberry Therapeutics has successfully raised a total of $23.77M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.06 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Conventional — $1.1M
-
First Round
First Round
(13 May 2015)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Debt – Conventional - Blueberry Therapeutics | Valuation |
investors |
|
| Jan, 2021 | Amount | Series B - Blueberry Therapeutics | Valuation | Medical Incubator Japan | |
| Aug, 2018 | Amount | Series B - Blueberry Therapeutics | Valuation | China Medical System |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Blueberry Therapeutics
Blueberry Therapeutics has secured backing from 6 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Maven Capital Partners, China Medical System and Medical Incubator Japan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Investment in innovative healthcare startups is facilitated by this company.
|
Founded Year | Domain | Location | |
|
Venture capital funds are managed for life sciences and growth businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Blueberry Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Blueberry Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blueberry Therapeutics Comparisons
Competitors of Blueberry Therapeutics
Blueberry Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Acorda, Liquidia, Genedit and NanoSyrinx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| domain | founded_year | HQ Location |
Engineered particles & films for life and material sciences applications
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Blueberry Therapeutics
Frequently Asked Questions about Blueberry Therapeutics
When was Blueberry Therapeutics founded?
Blueberry Therapeutics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is Blueberry Therapeutics located?
Blueberry Therapeutics is headquartered in Alderley Edge, United Kingdom. It is registered at Alderley Edge, Cheshire, United Kingdom.
Is Blueberry Therapeutics a funded company?
Blueberry Therapeutics is a funded company, having raised a total of $23.77M across 5 funding rounds to date. The company's 1st funding round was a Series B of $12.76M, raised on May 13, 2015.
How many employees does Blueberry Therapeutics have?
As of May 31, 2021, the latest employee count at Blueberry Therapeutics is 16.
What is the annual revenue of Blueberry Therapeutics?
Annual revenue of Blueberry Therapeutics is $615.53K as on May 31, 2019.
What does Blueberry Therapeutics do?
Blueberry Therapeutics is a modern drug discovery and development company specializing in polymer-drug delivery. Its nanopolymer drug delivery system self-assembles with both small and large molecules (e.g. proteins, peptides, and nucleic acids) and packages them into nanoparticles. These nanoparticles enhance cellular delivery into both mammalian and bacterial cells. It is developing OTC products to treat Onychomycosis (fungal nail infection), tinea pedis (athletes foot), acne, and acute wounds. Also developing prescription peptide therapeutics to treat Atopic Dermatitis, Inflammatory Bowel Disease.
Who are the top competitors of Blueberry Therapeutics?
Blueberry Therapeutics's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
What products or services does Blueberry Therapeutics offer?
Blueberry Therapeutics offers Nanopolymer Drug Delivery System and Therapy for Onychomycosis.
Who are Blueberry Therapeutics's investors?
Blueberry Therapeutics has 6 investors. Key investors include Maven Capital Partners, China Medical System, Medical Incubator Japan, Omar Ibrahimi, and InClin.